Clinical Trial Update: A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease) [Phase 2]

View source ↗

Summary

A Phase 2 study investigated GW856553 in patients with chronic obstructive pulmonary disease. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GW856553

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive, Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED